Authors
Christophe Dufossé is senior strategic marketing manager Next-Gen Bioprocessing, Merck KGaA, Darmstadt, Germany.
Greg Swan is business development manager, cell & gene therapies, at Avantor.
Bill Holt, DO, is vice president, Neuroscience Therapeutic Area, at ICON.
Vasileios Toxavidis is senior solutions product manager at Beckman Coulter Life Sciences.
Paul Romness, MHP, is chair and CEO of OS Therapies, a company developing novel immunotherapies for cancers like osteosarcoma and other solid tumors.
John Tomtishen is senior vice-president and general manager (IDMO Business), Cellares.
Eric Bankos is seniorcommissioning, qualification, and validationengineer atGenesisAEC.
Stefan Foser is VP Global Pharma at Bruker Daltonics.
Carrie Bracco is head of business development, US, at Novartis Contract Manufacturing
Yasmin Timol is project manager and market researcher at BioPlan Associates.
Joseph Zeleznik is technical product director, IMCD US
Dr. Athenecia Faggins is Director of Minaris Advanced Therapies
Erik Digman Wiklund is CEO of Circio. He has deep scientific knowledge in RNA and cancer biology and 13 years of pharma and biotech industry experience in a variety of functions including R&D, finance and business development. Wiklund holds a PhD in molecular biology from Aarhus University in Denmark and the Garvan Institute of Medical Research in Sydney, Australia.
Dario Zagallo is SME Study Monitor - EMEA Technology Excellence Center (TEC) Analytics at Stevanato Group.
Georgia Sloboda is managing director of Chemistry Manufacturing and Controls, Sia/LBG.
Chris Chen is the CEO of WuXi Biologics. Dr Chen served on the International Board of Directors for ISPE and holds a PhD in Chemical Engineering from the University of Delaware.
Fei Chen, PhD, is head, Cell Line Development, at WuXi Biologics.
Israel Ortíz is vice president and general manager at Accruent.
Dr. Vibha Jawa is Chief Scientific Officer at EpiVax, where she leads scientific strategy and innovation in immunogenicity and translational science. Previously, she held leadership roles at Bristol Myers Squibb, Merck, and Amgen, supporting biologics, vaccines, and cell and gene therapy development. With more than 20 years of industry experience, she has contributed to more than 20 IND, BLA, and MAA filings. Jawa has authored more than 75 peer-reviewed publications and serves in multiple leadership roles within AAPS and other scientific organizations. She was named an AAPS Fellow in 2022.
Venkat Reddy Sunkara is Global Head, Regulatory Affairs and CMC at ICON.
Emily Schoenthaler is content producer for BioPharm International®.
Laurent Levy is CEO of Nanobiotix.
Hang Zhou, PhD, is head of Bioprocess Research & Development, WuXi Biologics.
Shaalan Beg is chief medical officer, oncology at ConcertAI.
Dr. Alexander N. Shoushtari, MD, is a highly regarded, board-certified medical oncologist and cellular therapist practicing at the Memorial Sloan Kettering Cancer Center (MSK) in New York, NY. He has over 15 years of medical experience and runs the largest practice within MSK's Melanoma Service.